Metabolic Syndrome Stack
Improve insulin sensitivity, reduce visceral fat, optimize metabolic health
Overview
Advanced stack addressing multiple metabolic pathways: Tesamorelin for GH-mediated visceral fat reduction, MOTS-C for mitochondrial function and insulin sensitivity, Mazdutide for dual GLP-1/Glucagon effects.
Peptides in this Protocol
1
2
3
Protocol Details
| Duration | 24+ weeks |
| Timing | Tesamorelin: morning, fasted. MOTS-C: pre-workout. Mazdutide: same day/time each week. |
Notes
Requires careful monitoring and gradual dose escalation for Mazdutide. Particularly relevant for research in metabolic syndrome, type 2 diabetes, and obesity.